Please assess the completion status of the following clinical trial:

Trial Title: Hydrogen Therapy in Patients With Moderate Covid-19

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Patient ≥18 years old~2. Suspicion of SARS CoV-2 infection based on clinical signs AND (positive PCR OR positive serology OR suggestive abnormalities on lung-imaging modalities)~3. Hospitalized patients with SpO2 ≤94% on room air requiring normobaric oxygen therapy with a nasal flow of O2 ≤ 6L / min to reach at least SaO2 ≥ 95%~4. Patient understanding and agreeing to comply with the planned study procedures~5. Patient affiliated with social security or beneficiary of such protection~6. Patient (or his legal representative) who has given his informed consent in writing before the start of any study procedure.~Exclusion Criteria:~1. Pregnant or parturient women~2. Ratio of spontaneous blood ALT/AST\> 5 times the normal upper limit.~3. Stage 4 of severe chronic kidney disease or requiring dialysis (i.e. eGFR \<30)~4. Early transfer to another hospital within 72 hours.~5. Contraindication to any study drug, including a known allergy~6. Uncontrolled and clinically significant heart disease, such as arrhythmias, angina pectoris or uncompensated congestive heart failure~7. Patients treated in ambulatory care (i.e. not hospitalized)~8. Females of childbearing potential, defined as a premenopausal female capable of becoming pregnant, and not using an highly effective form of birth control.~9. Participant involved in another interventional clinical study~10. Person deprived of liberty by judicial order~11. Person under guardianship or curatorship

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental group (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).